The DOI matches its Crossref record; the references it cites are not checked yet.
Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections
Abstract
Intravitreal injections have become the most commonly performed intraocular treatments worldwide. Because intravitreal injections may induce severe adverse events, such as infectious and noninfectious endophthalmitis, cataract, ocular hypertension, vitreous hemorrhage, or retinal detachment, appropriate awareness of the materials and techniques used are essential to reduce these sight-threatening complications. This review provides insights into the needles, syringes, silicone oil coating, sterilization methods, devices to assist intravitreal injections, scleral piercing techniques using needles, syringe handling, anesthesia, and safety issues related to materials and techniques. It is paramount that physicians be aware of every step involved in intravitreal injections and consider the roles and implications of all materials and techniques used. The ability to understand the theoretical and practical circumstances may definitely lead to state-of-the-art treatments delivered to patients. The most important practical recommendations are: choosing syringes with as little silicone oil as possible, or, preferably, none; avoiding agitation of syringes; awareness that most biologics (e.g., antiangiogenic proteins) are susceptible to changes in molecular properties under some conditions, such as agitation and temperature variation; understanding that improper materials and techniques may lead to complications after intravitreal injections, e.g., inflammation; and recognizing that som…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Protein aggregation or change in conformation is a possible etiology of sterile uveitis/endophthalmitis.
“Protein aggregation or change in conformation has been studied more recently as a possible etiology of sterile uveitis/endophthalmitis [55, 56].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [55]
Various factors can contribute to SO release from the inner cylinder wall, protein denaturing, or both.
“Various factors can contribute to SO release from the inner cylinder wall, protein denaturing, or both [55, 57–59].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [55]
Many processes involved in shipping, handling and storage of anti-VEGF medications and syringes can contribute to SO release and protein aggregation.
“Many processes involved in the shipping, handling and storage of anti-VEGF medications and syringes can contribute to SO release and protein aggregation [55, 57–59].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [55]
Flicking the syringe to separate air from fluid contributes to SO release and is unnecessary due to the amount of drug in the original vial.
“This contributes to SO release and this maneuver is unnecessary due to the amount of drug in the original vial [55, 56].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [55]
Citations
The citation lists haven’t been fetched yet
References 175 · Cited by 114
Research works printed but not linked: 163
- Güler, 2015, Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection, Kor. J. Ophthalmol., 29, 190, 10.3341/kjo.2015.29.3.190 · DOI
- Örnek, 2014, Anesthetic effectiveness of topical levobupivacaine 0.75% versus topical proparacaine 0.5% for intravitreal injections, Saudi J. Anaesth., 8, 198, 10.4103/1658-354X.130713 · DOI
- Soliman, 2004, Comparative clinical trial of topical anesthetic agents in cataract surgery: lidocaine 2% gel, bupivacaine 0.5% drops, and benoxinate 0.4% drops, J. Cataract Refract. Surg., 30, 10.1016/j.jcrs.2003.12.034 · DOI
- Aderman, 2018, Comparing 33-gauge versus 30-gauge needles for intravitreal injections, Ophthalmol. Retina, 2, 1078, 10.1016/j.oret.2018.05.003 · DOI
- Agra, 2019, Silicone oil found in syringes commonly used for intravitreal injections, Arq. Bras. Oftalmol., 82, 354, 10.5935/0004-2749.20190080 · DOI
- Ahmad, 2019, Under-dosing of drug due to inaccurate syringe markings: vigilance and Quality control-the need of the hour, J. Clin. Anesth., 52, 121, 10.1016/j.jclinane.2018.09.023 · DOI
- Aiello, 2004, Evolving guidelines for intravitreous injections, Retina, 24, 10.1097/00006982-200410001-00002 · DOI
- Andrade, 2015, Comparison of 3 different anesthetic approaches for intravitreal injections: a prospective randomized trial, Arq. Bras. Oftalmol., 78, 27, 10.5935/0004-2749.20150008 · DOI
- Avery, 2014, Intravitreal injection technique and monitoring: update guidelines of an expert panel, Retina, 34, S1, 10.1097/IAE.0000000000000399 · DOI
- Avery, 2019, Large silicone droplets after intravitreal bevacizumab (Avastin), Retin. Cases Brief Rep., 13, 130, 10.1097/ICB.0000000000000570 · DOI
- Bakri, 2008, Intravitreal silicone oil droplets after intravitreal drug injections, Retina, 28, 996, 10.1097/IAE.0b013e31816c6868 · DOI
- Bakri, 2006, Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing, Retina, 26, 519, 10.1097/01.iae.0000225354.92444.7a · DOI
- Bakri, 2014, Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials, Ophthalmology, 121, 1102, 10.1016/j.ophtha.2013.11.029 · DOI
- Bantseev, 2019, Evaluation of surgical factors affecting vitreous hemorrhage following port delivery system with ranibizumab implant insertion in a minipig model, Retina
- Bardocci, 2003, Lidocaine 2% gel versus lidocaine 4% unpreserved drops for topical anesthesia in cataract surgery: a randomized controlled trial, Ophthalmology, 110, 144, 10.1016/S0161-6420(02)01562-2 · DOI
- Barnard, 2013, Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity, J. Pharm. Sci., 102, 915, 10.1002/jps.23415 · DOI
- Bartfield, 1994, A comparison of proparacaine and tetracaine eye anesthetics, Acad. Emerg. Med., 1, 364, 10.1111/j.1553-2712.1994.tb02646.x · DOI
- Basu, 2013, IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers, J. Pharm. Sci., 102, 852, 10.1002/jps.23434 · DOI
- Basu, 2014, Albinterferon α2b adsorption to silicone-oil water interfaces: effects of protein conformation, aggregation and subvisible particle formation, J. Pharm. Sci., 103, 427, 10.1002/jps.23821 · DOI
- Beaton, 2015, Non-invasive measurement of choroidal volume change and ocular rigidity through automated segmentation of high-speed OCT imaging, Biomed. Optic Express, 6, 1694, 10.1364/BOE.6.001694 · DOI
- Benz, 2006, Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide, Ophthalmology, 113, 1174, 10.1016/j.ophtha.2005.10.061 · DOI
- Blaha, 2011, Randomized trial of anesthetic methods for intravitreal injections, Retina, 31, 535, 10.1097/IAE.0b013e3181eac724 · DOI
- Boden, 2008, Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival, J. Cataract Refract. Surg., 34, 1773, 10.1016/j.jcrs.2008.05.056 · DOI
- Bracha, 2018, The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review, Surv. Ophthalmol., 63, 281, 10.1016/j.survophthal.2017.08.008 · DOI
- Bucher, 2005, Microbiologic studies of multiple-dose containers of triamcinolone acetonide and lidocaine hydrochloride, Retina, 25, 269, 10.1097/00006982-200504000-00003 · DOI
- Bucher, 2005, Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment, Arch. Ophthalmol., 123, 649, 10.1001/archopht.123.5.649 · DOI
- Campochiaro, 2019, The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial, Ophthalmology, 126, 1141, 10.1016/j.ophtha.2019.03.036 · DOI
- Chan, 2011, Investigating liquid leak from pre-filled syringes upon needle shield removal: effect of air bubble pressure, PDA J. Pharm. Sci. Technol., 65, 363, 10.5731/pdajpst.2011.00759 · DOI
- Chandra, 2018, The effectiveness of 2% lidocaine gel compared to 0,5% tetracaine eye drop as topical anesthetic agent for phacoemulsification surgery, Anesthesiol. Pain Med., 28
- Chaturvedi, 2019, Real-world trends in intravitreal injections practices among American retina specialists, Ophthalmol. Retina, 3, 656, 10.1016/j.oret.2019.03.023 · DOI
- Chavan, 2013, Review on needle free drug delivery systems, Int. J. Pharm. Rev. Res., 2, 30
- Chisholm, 2015, In vivo analysis of the potency of silicone oil microdroplets as immunological adjuvants in protein formulations, J. Pharm. Sci., 104, 3681, 10.1002/jps.24573 · DOI · Paper page
- Chisholm, 2016, Silicone oil microdroplets can induce antibody responses against recombinant murine growth hormone in mice, J. Pharm. Sci., 105, 1623, 10.1016/j.xphs.2016.02.019 · DOI
- Chisholm, 2017, Immunogenicity of structurally perturbed hen egg lysozyme adsorbed to silicone oil microdroplets in wild-type and transgenic mouse models, J. Pharm. Sci., 106, 10.1016/j.xphs.2017.02.008 · DOI · Paper page
- Closset, 2017, Physical stability of highly concentrated injectable drug solutions used in intensive care units, Ann. Pharm. Fr., 75, 185, 10.1016/j.pharma.2016.12.004 · DOI
- Crul, 2019, Bevacizumab for intravitreal injection: impact of sub-visible particles on the shelf-life of repackaged bevacizumab, J. Ocul. Pharmacol. Therapeut., 35, 372, 10.1089/jop.2019.0042 · DOI
- Davis, 2012, Comparison of topical anesthetics for intravitreal injections. A randomized clinical trial, Retina, 32, 701, 10.1097/IAE.0b013e31822f27ca · DOI
- De Bardi, 2018, On the needle clogging of staked-in-needle pre-filled syringes: mechanism of liquid entering the needle and solidification process, Eur. J. Pharm. Biopharm., 128, 272, 10.1016/j.ejpb.2018.05.006 · DOI
- De Stefano, 2011, Experimental investigation of needles, syringes and techniques for intravitreal injections, Clin. Exp. Ophthalmol., 39, 236, 10.1111/j.1442-9071.2010.02447.x · DOI
- Dedania, 2015, Sustained elevation of intraocular pressure after intravitreal anti-VEGF agents: what is the evidence?, Retina, 35, 841, 10.1097/IAE.0000000000000520 · DOI
- Deschenes, 2008, International uveitis study group (IUSG): clinical classification of uveitis, Ocul. Immunol. Inflamm., 16, 1, 10.1080/09273940801899822 · DOI
- Dias, 2020, Agitation of the syringe and silicone oil, Eye
- Dierick, 2016, Ready-to-use prefillable syringes: sterilisation effects on biopharmaceuticals, ONdrugDelivery Magazine, 71, 50
- Dill, 2019, Mechanical shock during shipping of medications: the roles of packaging and transportation vendors, J. Pharm. Sci., 30721
- Döge, 1985, [The storage capability of pre-filled disposable plastic syringes], Pharmazie, 40
- Doshi, 2011, Intravitreal injection technique, Semin. Ophthalmol., 26, 104, 10.3109/08820538.2010.541318 · DOI
- Doshi, 2011, Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis, Ophthalmic Surg. Laser. Imag., 42, 346, 10.3928/15428877-20110210-02 · DOI
- Eadie, 2017, Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery, JAMA. Ophthalmol., 135, 363, 10.1001/jamaophthalmol.2017.0059 · DOI
- Eaton, 2013, Assessment of novel guarded needle to increase patient comfort and decrease injection time during intravitreal injection, Ophthalmic Surg. Lasers Imaging Retina, 44, 561, 10.3928/23258160-20131105-06 · DOI
- Egekvist, 1999, Pain and mechanical injury of human skin following needle insertions, Eur. J. Pain, 3, 41, 10.1016/S1090-3801(99)90187-8 · DOI
- Emerson, 2017, Silicone oil droplets are more common in fluid from BD insulin syringes as compared to other syringes, J. VitreoRet. Dis., 1401-406
- Freund, 2006, Silicone oil droplets following intravitreal injections, Retina, 26, 701, 10.1097/01.iae.0000223177.08438.2b · DOI
- Friedrich, 1997, Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume, Curr. Eye Res., 16, 663, 10.1076/ceyr.16.7.663.5061 · DOI
- Funatsu, 2019, Impact of ethylene oxide sterilization of polymer-based prefilled syringes on chemical degradation of a model therapeutic protein during storage, J. Pharm. Sci., 108, 770, 10.1016/j.xphs.2018.09.029 · DOI
- Funke, 2015, Analysis of thin baked-on silicone layers by FTIR and 3D-laser scanning microscopy, Eur. J. Pharm. Biopharm., 96, 304, 10.1016/j.ejpb.2015.08.009 · DOI
- Gerhardt, 2013, Ionic strength affects tertiary structure and aggregation propensity of a monoclonal antibody adsorbed to silicone oil-water interfaces, J. Pharm. Sci., 102, 429, 10.1002/jps.23408 · DOI
- Gerhardt, 2015, Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes, J. Pharm. Sci., 104, 1601, 10.1002/jps.24387 · DOI
- Gerhardt, 2015, Surfactant effects on particle generation in antibody formulations in pre-filled syringes, J. Pharm. Sci., 104, 4056, 10.1002/jps.24654 · DOI
- Goldberg, 2012, An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab, Am. J. Ophthalmol., 153, 204, 10.1016/j.ajo.2011.11.035 · DOI
- Goldberg, 2014, Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes, Am. J. Ophthalmol., 158, 733, 10.1016/j.ajo.2014.06.019 · DOI · Paper page
- Gote, 2019, Ocular drug delivery: present innovations and future challenges, J. Pharmacol. Exp. Therapeut., 370, 602, 10.1124/jpet.119.256933 · DOI · Paper page
- Green-Simms, 2011, Survey of intravitreal injection techniques among retinal specialists in the United States, Am. J. Ophthalmol., 151, 329, 10.1016/j.ajo.2010.08.039 · DOI
- Greenberg, 2019, Aflibercept-related sterile intraocular inflammation outcomes, Ophthalmol. Retina, 3, 753, 10.1016/j.oret.2019.04.006 · DOI · Paper page
- Gregori, 2012, Randomized clinical trial of two anesthetic techniques for intravitreal injections: 4% liquid lidocaine on cotton swabs versus 3.5% lidocaine gel, Expert Opin. Drug Deliv., 9, 735
- Haas, 2016, Needle size in intravitreal injections- pain evaluation of a randomized clinical trial, Acta Ophthalmol., 94, 198, 10.1111/aos.12901 · DOI
- Hahn, 2015, Postmarketing analysis of aflibercept-related sterile intraocular inflammation, JAMA. Ophthalmol., 133, 421, 10.1001/jamaophthalmol.2014.5650 · DOI · Paper page
- Han, 2012, Models of the cutting-edge geometry of medical needles with applications to needle design, Int. J. Mech. Sci., 65, 157, 10.1016/j.ijmecsci.2012.09.014 · DOI
- Herrero-Vanrell, 2014, The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies, Prog. Retin. Eye Res., 42, 27, 10.1016/j.preteyeres.2014.04.002 · DOI
- Hicks, 1972, Stability of sodium bicarbonate injection stored in polypropylene syringes, Am. J. Hosp. Pharm., 29, 210
- Hubschman, 2010, Experimental model of intravitreal injection techniques, Retina, 30, 167, 10.1097/IAE.0b013e3181b094cf · DOI
- Jenke, 2014, Extractables and leachables considerations for prefilled syringes, Expet Opin. Drug Deliv., 11, 1591, 10.1517/17425247.2014.928281 · DOI
- Jones, 2005, Silicone oil induced aggregation of proteins, J. Pharm. Sci., 94, 918, 10.1002/jps.20321 · DOI
- Jones, 2018, Considerations for the use of polysorbates in biopharmaceuticals, Pharm. Res. (N. Y.), 35, 148, 10.1007/s11095-018-2430-5 · DOI
- Kahook, 2010, High-molecular-weight aggregates in repackage bevacizumab, Retina, 30, 887, 10.1097/IAE.0b013e3181d50cea · DOI
- Kelly, 1948, A note on intravitreous penicillin, Br. J. Ophthalmol., 32, 153, 10.1136/bjo.32.3.153 · DOI
- Kent, 2013, Striving to improve intravitreal injections, Rev. Ophthalmol., 20, 14
- Khalili, 2015, Storage stability of bevacizumab in polycarbonate and polypropylene syringes, Eye, 29, 820, 10.1038/eye.2015.28 · DOI
- Khurana, 2017, Presumed silicone oil droplets in the vitreous cavity after intravitreal bevacizumab injection with insulin syringes, JAMA. Ophthalmol., 135, 800, 10.1001/jamaophthalmol.2017.1815 · DOI
- Kiminami, 2017, Impact of sterilization method on protein aggregation and particle formation in polymer-based syringes, J. Pharm. Sci., 106, 1001, 10.1016/j.xphs.2016.12.007 · DOI
- Knecht, 2009, Tunneled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort, Retina, 29, 1175, 10.1097/IAE.0b013e3181aade74 · DOI
- Kozak, 2006, Prefilled syringe needles versus standard removable needles for intravitreous injection, Retina, 26, 679, 10.1097/01.iae.0000236481.40056.25 · DOI
- Krayukhina, 2015, Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins, J. Pharm. Sci., 104, 527, 10.1002/jps.24184 · DOI · Paper page
- Kumar, 2008, Assessment of comfort during intra‐ vitreal injections and comparison of anaesthetic drops and subconjunctival anaesthesia, Asian J. Ophthalmol., 10, 185
- Lad, 2006, Minimizing the risk of endophthalmitis following intravitreal injections, Compr. Ophthalmol. Update, 7, 277
- Lawerson, 1998, Comparison of the tolerability and efficacy of unit-dose, preservative-free topical ocular anesthetics, Ophthalmic Physiol. Optic., 18, 393, 10.1046/j.1475-1313.1998.00381.x · DOI
- Lee, 2019, Gene therapy for visual loss: opportunities and concerns, Prog. Retin. Eye Res., 68, 31, 10.1016/j.preteyeres.2018.08.003 · DOI
- Lemes, 2019, Effect of injection solutions in the dispersion of syringe lubricant (silicone oil), J. Am. Acad. Dermatol.
- Leopold, 1945, Intravitreal penetration of penicillin and penicillin therapy of infections of the vitreous, Arch. Ophthalmol., 33, 211, 10.1001/archopht.1945.00890150055008 · DOI
- Lesk, 2019, Intraocular pressure spikes following therapeutic intravitreal injections are correlated with ocular rigidity, Invest. Ophthalmol. Vis. Sci., 60, 2249
- Liu, 2011, Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling, Invest. Ophthalmol. Vis. Sci., 22, 1023, 10.1167/iovs.10-6431 · DOI · Paper page
- Lode, 2019, A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes, Sci. Rep., 9, 18021, 10.1038/s41598-019-54226-7 · DOI · Paper page
- Lopez-Guajardo, 2008, Reduction of pegaptanib loss during intravitreal delivery using an oblique injection technique, Eye, 22, 430, 10.1038/sj.eye.6703054 · DOI
- Lorenz, 2010, Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle, Graefes Arch. Clin. Exp. Ophthalmol., 248, 1573, 10.1007/s00417-010-1490-y · DOI
- Ludwig, 2011, Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations, Anal. Biochem., 410, 191, 10.1016/j.ab.2010.12.008 · DOI
- Maruno, 2018, Sweeping of adsorbed therapeutic protein on prefillable syringes promotes micro aggregate generation, J. Pharm. Sci., 107, 1521, 10.1016/j.xphs.2018.01.021 · DOI
- Mehta, 2015, Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation, J. Pharm. Sci., 104, 1282, 10.1002/jps.24358 · DOI
- Mehta, 2016, Colloidal instability fosters agglomeration of subvisible particles created by rupture of gels of a monoclonal antibody formed at silicone oil-water interfaces, J. Pharm. Sci., 105, 2338, 10.1016/j.xphs.2016.06.010 · DOI
- Melo, 2019, Release of silicone oil from syringes, Int. J. Retina Vitreous, 5, 1, 10.1186/s40942-018-0153-8 · DOI · Paper page
- Melo, 2019, Prevalence of silicone oil droplets in eyes treated with intravitreal injection, Int. J. Retina Vitreous, 5, 34, 10.1186/s40942-019-0184-9 · DOI
- Melo, 2019, Release of silicone oil and the off-label use of syringes in ophthalmology, Br. J. Ophthalmol.
- Melo, 2019, Needles as a source of silicone oil during intravitreal injection, Eye, 33, 1025, 10.1038/s41433-019-0365-7 · DOI
- Melo, 2019, Inflammatory reaction after aflibercept intravitreal injections associated with silicone oil droplets released from syringes: a case-control study, Ophthalmic Surg. Lasers Imaging Retina, 50, 288, 10.3928/23258160-20190503-05 · DOI · Paper page
- Melo, 2020, Survey among retina specialists in Brazil about inflammatory reactions after intravitreal antiangiogenic therapy, Arq. Bras. Oftalmol., 83, 10.5935/0004-2749.20200031 · DOI
- Merani, 2015, Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review, Int. J. Retina Vitreous, 21, 1
- Nakamura, 2015, A strategy for the prevention of protein oxidation by drug product in polymer-based syringes, PDA J. Pharm. Sci. Technol., 69, 88, 10.5731/pdajpst.2015.01009 · DOI
- Nakamura, 2015, Assessment of the effects of sterilization methods on protein drug stability by elucidating decomposition mechanism and material analysis, Int. J. Pharm., 484, 51, 10.1016/j.ijpharm.2015.02.020 · DOI
- Özkaya, 2013, Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure, J. Ocul. Pharmacol. Therapeut., 29, 325, 10.1089/jop.2012.0144 · DOI
- Pacheco, 2013, Effects of microparticle size and Fc density on macrophage phagocytosis, PloS One, 8, 10.1371/journal.pone.0060989 · DOI
- Palmer, 2013, Quality of bevacizumab compounded for intravitreal administration, Eye, 27, 1090, 10.1038/eye.2013.139 · DOI
- Pang, 2015, Association between needle size, postinjection reflux and intraocular pressure spikes after intravitreal injections, Retina, 35, 1401, 10.1097/IAE.0000000000000476 · DOI
- Patel, 2013, Toxicity of topical ophthalmic anesthetics, Expet Opin. Drug Metabol. Toxicol., 9, 983, 10.1517/17425255.2013.794219 · DOI
- Peláez, 2018, Container closure integrity testing of prefilled syringes, J. Pharm. Sci., 107, 2091, 10.1016/j.xphs.2018.03.025 · DOI
- Perera, 2019, Probing the interfacial interactions of monoclonal and bispecific antibodies at the silicone oil-aqueous solution interface by using sum frequency generation vibrational spectroscopy, Langmuir, 35, 14339, 10.1021/acs.langmuir.9b02768 · DOI
- Peterson, 2019, Long-term physical stability, sterility, and anti-VEGF bioactivity of repackaged bevacizumab in 2-mL glass vials, Retina, 39, 1802, 10.1097/IAE.0000000000002212 · DOI
- Pulido, 2007, The use of 31-gauge needles and syringes for intraocular injections, Eye, 21, 829, 10.1038/sj.eye.6702514 · DOI
- Pulido, 2007, Scleral penetration force requirements for commonly used intravitreal needles, Eye, 21, 1210, 10.1038/sj.eye.6702577 · DOI
- Qadry, 1999, Model development for O2 and N2 permeation rates through CZ-resin vials, Int. J. Pharm., 188, 173, 10.1016/S0378-5173(99)00220-3 · DOI
- Randolph, 2015, Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation, J. Pharm. Sci., 104, 602, 10.1002/jps.24259 · DOI
- Ratnarajan, 2013, Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique, Br. J. Ophthalmol., 97, 395, 10.1136/bjophthalmol-2012-302155 · DOI
- Rifkin, 2012, Factors affecting patients' pain intensity during in office intravitreal injection procedure, Retina, 32, 696, 10.1097/IAE.0b013e3182252ad3 · DOI
- Rodrigues, 2007, Tunneled scleral incision to prevent vitreal reflux after intravitreal injection, Am. J. Ophthalmol., 143, 1035, 10.1016/j.ajo.2007.01.035 · DOI
- Rodrigues, 2009, Therapeutic monoclonal antibodies in ophthalmology, Prog. Retin. Eye Res., 28, 117, 10.1016/j.preteyeres.2008.11.005 · DOI
- Rodrigues, 2011, Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection, J. Ocul. Pharmacol. Therapeut., 27, 197, 10.1089/jop.2010.0082 · DOI
- Sacha, 2010, Practical fundamentals of glass, rubber, and plastic sterile packaging systems, Pharmaceut. Dev. Technol., 15, 6, 10.3109/10837450903511178 · DOI
- Sasajima, 2018, A randomized trial of a short 34-gauge needle for intravitreal injections, Ophthalmology, 125, 947, 10.1016/j.ophtha.2018.01.038 · DOI
- Sayah, 2020, Non-invasive in vivo measurement of ocular rigidity: clinical validation, repeatability and method improvement, Exp. Eye Res., 190, 107831, 10.1016/j.exer.2019.107831 · DOI
- Schargus, 2018, Contamination of anti-VEGF drugs for intravitreal injection: how do repackaging and newly developed syringes affect the amount of silicone oil droplets and protein aggregates?, Retina, 38, 2088, 10.1097/IAE.0000000000001809 · DOI
- Schmidt-Erfurth, 2007, Management of neovascular age-related macular degeneration, Prog. Retin. Eye Res., 26, 437, 10.1016/j.preteyeres.2007.03.002 · DOI
- Scott, 2009, SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design, Am. J. Ophthalmol., 148, 725, 10.1016/j.ajo.2009.06.004 · DOI
- Scurlock, 1978, The clinical character of local anesthetics: a function of frequency-dependent conduction block, Acta Anesth. Scand., 22, 601, 10.1111/j.1399-6576.1978.tb01343.x · DOI
- Shah, 2010, A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia, Local Reg. Anesth., 57
- Shiroma, 2014, Safety and efficacy of various concentrations of topical lidocaine gel for intravitreal injection, Expet Opin. Drug Saf., 13, 1299, 10.1517/14740338.2014.947261 · DOI
- Shiroma, 2017, Patient pain during intravitreal injections under topical anesthesia: a systematic review, Int. J. Retina Vitreous, 3, 23, 10.1186/s40942-017-0076-9 · DOI
- Shiroma, 2019, RE: stem MS, et al: predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength, Ophthalmol Retina, 3, 3
- Sitzman, 1996, The effects of needle type, gauge, and tip bend on spinal needle deflection, Anesth. Analg., 82, 297
- Small, 2019, Fungal endophthalmitis after intravitreal injections of triamcinolone contaminated by a compounding pharmacy: five-year follow-up of 23 patients, Ophthalmol. Retina, 3, 133, 10.1016/j.oret.2018.09.009 · DOI
- Speaker, 1991, A study of the interaction of selected drugs and plastic syringes, J. Parenter. Sci. Technol., 45, 212
- Stem, 2019, Predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength, Ophthalmol. Retina, 3, 3, 10.1016/j.oret.2018.09.013 · DOI
- Symington, 2006, A review of the use of propofol for procedural sedation in the emergency department, Emerg. Med. J., 23, 89, 10.1136/emj.2005.023713 · DOI
- Ta, 2004, Minimizing the risk of endophthalmitis following intravitreous injections, Retina, 24, 699, 10.1097/00006982-200410000-00003 · DOI
- Tah, 2015, Anti-VEGF therapy and the retina: an update, J. Ophthalmol., 2015, 627674, 10.1155/2015/627674 · DOI
- Teska, 2016, Aggregation and particle formation of therapeutic proteins in contact with a novel fluoropolymer surface versus siliconized surfaces: effects of agitation in vials and in prefilled syringes, J. Pharm. Sci., 105, 2053, 10.1016/j.xphs.2016.04.015 · DOI
- Thirumangalathu, 2009, Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution, J. Pharm. Sci., 98, 3167, 10.1002/jps.21719 · DOI
- Thompson, 2011, Advantages and limitations of small gauge vitrectomy, Surv. Ophthalmol., 56, 162, 10.1016/j.survophthal.2010.08.003 · DOI
- Torisu, 2017, Friability testing as a new stress-stability assay for biopharmaceuticals, J. Pharm. Sci., 106, 2966, 10.1016/j.xphs.2017.05.035 · DOI · Paper page
- Tufan, 2013, Bacterial contamination of needles used for intravitreal injections: comparison between 27-gauge and 30-gauge needles, Ocul. Immunol. Inflamm., 21, 366, 10.3109/09273948.2013.801988 · DOI
- Uchino, 2015, Reconstitution of L-asparaginase in siliconized syringes with shaking and headspace air induces protein aggregation, Chem. Pharm. Bull., 63, 770, 10.1248/cpb.c15-00242 · DOI
- Ueda, 2019, Effects of product handling parameters on particle levels in a commercial Factor VIII product: impacts and mitigation, J. Pharm. Sci., 108, 775, 10.1016/j.xphs.2018.08.022 · DOI
- Ullrich, 2016, Assistive device for efficient intravitreal injections, Ophthalmic Surg. Lasers Imaging Retina, 47, 752, 10.3928/23258160-20160808-09 · DOI
- Van Asten, 2015, Are intravitreal injections with ultrathin 33-g needles less painful than the commonly used 30-G needles?, Retina, 35, 1778, 10.1097/IAE.0000000000000550 · DOI
- VanderBeek, 2019, The argument for sterile loading of all intravitreal injections and the benefit of replicated results, JAMA. Ophthalmol., 137, 343, 10.1001/jamaophthalmol.2018.7089 · DOI
- Waqar, 2019, Comment on: optimisation of intravitreal injection technique using a Barraquer speculum with solid flat blade and finger stabilisation, Eye, 33, 512, 10.1038/s41433-018-0248-3 · DOI
- Waxman, 2017, A comparison of protein stability in prefillable syringes made of glass and plastic, PDA J. Pharm. Sci. Technol., 71, 462, 10.5731/pdajpst.2016.007146 · DOI
- Wells, 2016, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial, Ophthalmology, 123, 1351, 10.1016/j.ophtha.2016.02.022 · DOI
- Wen, 2017, Intravitreal anti-VEGF injections reduce aqueous outflow facility in patients with neovascular age-related macular degeneration, Invest. Ophthalmol. Vis. Sci., 58, 1893, 10.1167/iovs.16-20786 · DOI
- Werner, 2019, Silicone oil-free polymer syringes for the storage of therapeutic proteins, J. Pharm. Sci., 108, 1148, 10.1016/j.xphs.2018.10.049 · DOI
- Williams, 2014, IVT injections: health policy implications, Rev. Ophthalmol., 21, 62
- Wood, 2019, Nanovitreoretinal subretinal gateway device to displace submacular hemorrhage: access to the subretinal space without vitrectomy, Retina
- Xu, 2012, Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade, Invest. Ophthalmol. Vis. Sci., 53, 5221, 10.1167/iovs.12-9702 · DOI
- Yahalomi, 2019, Reduction of postintravitreal injection pain using ice: an open-label interventional randomized controlled trial, Retina
- Yannuzzi, 2015, Evaluation of compounded bevacizumab prepared for intravitreal injection, JAMA. Ophthalmol., 133, 32, 10.1001/jamaophthalmol.2014.3591 · DOI
- Yau, 2011, Intravitreal injection anesthesia - comparison of different topical agents: a prospective randomized controlled trial, Am. J. Ophthalmol., 151, 333, 10.1016/j.ajo.2010.08.031 · DOI
- Yoshino, 2014, Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system, J. Pharm. Sci., 103, 1520, 10.1002/jps.23945 · DOI
Metadata
- Authors
- Melo, G. B., Cruz, N. F. S. D., Emerson, G. G., Rezende, F. A., Meyer, C. H., Uchiyama, S., Carpenter, J., Shiroma, H. F., Farah, M. E., Maia, M., & Rodrigues, E. B.
- Affiliations
- Universidade Federal de São Paulo (BR)
- The Retina Center (US)
- Hôpital Maisonneuve-Rosemont (CA)
- Philipps University of Marburg (DE)
- The University of Osaka (JP)
- University of Colorado Denver (US)
- Saint Louis University Hospital (US)
- Corresponding author
- Melo, Gustavo Barreto
- ORCID
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 80
- Pages
- 100862
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W3016654382
- Cited by
- 114
- References
- 175
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 15 · 2023: 18 · 2022: 14 · 2021: 18
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Retinal and Eye Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Agency for Medical Research and Development
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Pan-American Association of Ophthalmology
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- intravitreal injection, syringes, needles, silicone oil coating, sterilization, endophthalmitis, ocular hypertension, vitreous hemorrhage, retinal detachment, injection complications, injection safety
- MeSH terms
- Animals, Disposable Equipment, Humans, Needles, Silicone Oils, Syringes, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review